US Patent 11214536 Polymorphs and uses thereof
All edits
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+383 characters)
Article
Patent abstract
The present invention relates to new polymorphs of LXRβ agonists which exhibit improved physical properties. The invention also relates to pharmaceutical compositions including a pharmaceutically effective amount of an LXRβ agonist, as well as methods of treating cancer including administration of a formulation including an LXRβ agonist to a subject in need thereof.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hayley Reece0
Saurabh Chitre0
Stephen Wald0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112145360
Date of Patent
January 4, 2022
0Patent Application Number
167655320
Date Filed
November 20, 2018
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11214536 Polymorphs and uses thereof
Infobox
Is a
Patent jurisdiction
Patent number
11214536
Date of patent
January 4, 2022
Patent application number
16765532
Date Filed
November 20, 2018
Patent primary examiner
Find more entities like US Patent 11214536 Polymorphs and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.